1,3-dipropyl-8-(4-sulfophenyl)xanthine has been researched along with n-benzo(1,3)dioxol-5-yl-2-(5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1h-purin-8-yl)-1-methyl-1h-pyrazol-3-yloxy)-acetamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Baskin, II; Ivanov, AA; Palyulin, VA; Piccagli, L; Zefirov, NS | 1 |
1 other study(ies) available for 1,3-dipropyl-8-(4-sulfophenyl)xanthine and n-benzo(1,3)dioxol-5-yl-2-(5-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1h-purin-8-yl)-1-methyl-1h-pyrazol-3-yloxy)-acetamide
| Article | Year |
|---|---|
Molecular modeling and molecular dynamics simulation of the human A2B adenosine receptor. The study of the possible binding modes of the A2B receptor antagonists.
Topics: Adenosine A2 Receptor Antagonists; Amino Acid Sequence; Binding Sites; Computer Simulation; Humans; Lipid Bilayers; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Phospholipids; Receptor, Adenosine A2B; Water | 2005 |